-
Adverse Events Post-Colonoscopy Rise With Age but Are Rare
13 Jun 2025 07:12 GMT
… 30 days post-procedure for adverse events.
Outcomes included emergency department … age and adverse event risk, adjusting for various factors.
TAKEAWAY:
Adverse events occurred in … .
Significant risk factors for adverse events across all age groups included …
-
Topical Ruxolitinib Emerges as Promising Therapy for Diverse Inflammatory Skin Conditions
18 Jun 2025 04:25 GMT
… present a lower risk of adverse events and drug interactions compared with …
-
Dyne Therapeutics Stock Drops After ‘Surprise’ Pivot In Primary Endpoint For Muscle Drug Trial
18 Jun 2025 04:19 GMT
… , with no treatment-related serious adverse events in the 56 participants dosed …
-
Epcoritamab Plus Chemoimmunotherapy Yields 87% Response Rate in R/R DLBCL; 65% Proceed to Transplant
18 Jun 2025 04:26 GMT
… -free. All patients were alive.
Adverse events (AEs). The most common treatment …
-
Immuneering’s Positive Pancreatic Cancer Trial Data Sparks Bullish Retail Sentiment Even As Profit-Taking Cools Rally
18 Jun 2025 04:19 GMT
… .
No Grade 3 or higher adverse events were observed across most categories …
-
New Data Supports TNX-102 SL Efficacy Ahead of PDUFA
18 Jun 2025 01:41 GMT
… the study, with treatment-emergent adverse events (AEs) leading to discontinuation in … patients on placebo had serious adverse events, 1 event of acute pancreatitis …
-
Inside the ASX Biotech Boom: What’s Fuelling the Next Wave
18 Jun 2025 00:30 GMT
… -PET scans) and no serious adverse events across six treatment cycles.
A … no treatment-related pain or adverse events and early indications of lesion …
-
Experts to discuss MedDRA's crucial role in global medical research through standardizing clinical trials
18 Jun 2025 02:31 GMT
… clinical trials, disparate interpretations of adverse events and medical conditions can lead …
-
New Board Members Appointed To The Health Quality & Safety Commission
18 Jun 2025 04:16 GMT
… HQSC areas of work include adverse events, building
leadership and capability, improved …
-
Cero Therapeutics Rockets On FDA Orphan Drug Status For Blood Cancer Drug; Retail Bulls Feel Stock 'Still Has A Few Pumps Left'
18 Jun 2025 04:19 GMT
… objectives include the frequency of adverse events, dose-limiting toxicities, estimated overall …